Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Safety Study in Subjects Using Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

NCT00701155 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00701155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00701155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Safety Study in Subjects Using Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
March 31, 2008
Enrollment
3,593 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1, diabetes mellitus, type 2